Dr. Luis E. Velez, MD

Dr. Velez practices at Total Vascular Care in San Antonio, Texas.

Dr. Velez's NPI, 1053328336, was assigned on August 1, 2006. Dr. Velez graduated from Institute of Health Sciences Medellin Faculty of Medicine in 1999. Dr. Velez holds Texas license L9948.

Dr. Velez's primary practice is Total Vascular Care, at 215 N San Saba, Suite 201, San Antonio, TX 78207. The practice phone is (210) 212-8622.

Dr. Velez's primary practice is Total Vascular Care in San Antonio, Texas. Dr. Velez is also affiliated with Methodist Hospital. The medical group on file is South Texas Renal Care Group. Dmand AI also links Dr. Velez to 2 more hospitals, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Velez practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Velez's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Velez is board certified in nephrology by the American Board of Internal Medicine. Dr. Velez is licensed in Texas.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Velez treats.

CMS data shows 1,125 Medicare services from Dr. Velez across 8 procedure codes in 2024, for 287 Medicare patients. Medicare paid $102,537 for them.

CMS counts 287 Medicare patients who saw Dr. Velez in 2024. The largest group is 75 to 84, with 100 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 4.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Velez's median patient age at 68, with 51% women.

In 2024, Dr. Velez wrote 1,811 Medicare Part D claims for 323 patients. 77% of them were for generic drugs. CMS names the drug for 1,562 of them, across 37 drugs with 11 or more claims each, at $557,691 in total drug cost. In 2023, CMS named 1,002 claims across 29 drugs.

Dr. Velez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1,013 general payments to Dr. Velez from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $332,083.

Dmand AI lists 1 award for Dr. Velez, most recently CMS Stage 1 EHR in 2012.

Dr. Velez graduated from Institute of Health Sciences Medellin Faculty of Medicine in 1999.

Dr. Velez is in network with 22 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.